Table 4.
Use of vasoactive medications
| Medication | Survivors, n = 14 | Non-survivors, n = 23 | P-value |
|---|---|---|---|
| Dobutamine | 64% (9) | 57% (13) | 0.96 |
| Milrinone | 50% (7) | 70% (16) | 0.20 |
| Vasopressors | 29% (4) | 91% (21) | <0.0001 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.